Monte Rosa Therapeutics, Inc. (GLUE) vs Lyell Immunopharma, Inc. (LYEL)
Detailed comparison between Monte Rosa Therapeutics, Inc., Lyell Immunopharma, Inc..Total Return (%)
Monte Rosa Therapeutics, Inc. (GLUE)Lyell Immunopharma, Inc. (LYEL)
Which stock do you think will perform better?
Monte Rosa Therapeutics, Inc.
GLUE
Lyell Immunopharma, Inc.
LYEL
| Metric | Monte Rosa Therapeutics, Inc. (GLUE) | Lyell Immunopharma, Inc. (LYEL) |
|---|---|---|
| Current Price | $14.09 | $18.20 |
| Change | 0.57 (4.22%) | 0.77 (4.42%) |
| Market Cap | $0.92B | $0.39B |
| Trailing P/E | 44.03 | 0.00 |
| Forward P/E | -9.39 | -21.67 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $14.62 | $20.80 |
| 52-Week Low | $3.50 | $7.65 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $0.32 | $-22.75 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| GLUE | 50.70% | 154.79% | 65.96% | -33.47% | -33.47% | -33.47% |
| LYEL | 6.87% | 57.99% | -4.21% | -94.61% | -94.61% | -94.61% |